Axcella Health Inc.
AXLADelisted Feb 15, 2024- Industry
- Biological Products, (No Diagnostic Substances)
- SEC CIK
- 0001633070
Axcella Health Inc. was delisted on Feb 15, 2024; its insiders filed their last Form 4 on Mar 3, 2023; 15 institutions reported holding it in 13F filings for Q3 2023, worth $17.1M in total; no superinvestor held it.
Q2 2022 vs. Q1 2022
How the institutions holding Axcella Health Inc. changed between Q1 2022 and Q2 2022.
All holders in Q2 2022All holders in Q1 2022
| Measure | Q1 2022 | Q2 2022 | Change |
|---|---|---|---|
| Holders | 38 | 34 | −4 |
| Shares | 33.9M | 34.1M | +203.4K (+0.6%) |
| Value | $87.0M | $69.2M | −$17.9M (−20.5%) |
New holders (3)
Institutions that held Axcella Health Inc. at the end of Q2 2022 but not at the end of Q1 2022.
| Institution | Shares | Value | % of portfolio |
|---|---|---|---|
| Charles Schwab Investment Management Inc | 18,250 | $38.0K | 0.00% |
| Citadel Advisors LLC | 12,774 | $26.0K | 0.00% |
| Susquehanna International Group, LLP | 11,709 | $24.0K | 0.00% |
Sold out (7)
Institutions that held Axcella Health Inc. at the end of Q1 2022 and filed for Q2 2022 without it.
| Institution | Shares, Q1 2022 | Value, Q1 2022 |
|---|---|---|
| Millennium Management LLC | 39,853 | $102.0K |
| Acadian Asset Management LLC | 8,959 | $23.0K |
| Advisor Group Holdings, Inc. | 5,000 | $13.0K |
| American Portfolios Advisors | 400 | $1.03K |
| Federated Hermes, Inc. | 503 | $1.00K |
| Northwestern Mutual Wealth Management Co | 300 | $1.00K |
| Bank of America Corp | 54 | $0 |